Mariner
INMB icon

Mariner’s INmune Bio INMB Stock Holding History

Mariner’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.5K Buy
19,043
+8,793
+86% +$12.5K ﹤0.01% 3488
2025
Q4 		$16K Sell
10,250
-2,081
-17% -$3.71K ﹤0.01% 3494
2025
Q3 		$25.5K Buy
12,331
+1,452
+13% +$3.32K ﹤0.01% 3500
2025
Q2 		$25.1K Buy
+10,879
New +$79.8K ﹤0.01% 3402
2025
Q1 		– Sell
-13,836
Closed -$64.6K – 3522
2024
Q4 		$64.6K Buy
+13,836
New +$72.1K ﹤0.01% 3258

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mariner's INMB Position: Q1 2026 in Review

Mariner increased its INmune Bio (INMB) stake by 86% in Q1 2026, buying an estimated $12.5K and bringing the position to 19,043 shares worth $21.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3488.

Mariner first reported a position in INMB in Q4 2024 and has held it in 5 quarters since. The position peaked at $64.6K in Q4 2024. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Mariner held 19,043 shares of INmune Bio worth $21.5K as of Q1 2026.
  • Mariner bought 8,793 INmune Bio shares in Q1 2026, an estimated $12.5K.
  • INmune Bio made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #3488 holding.
  • Mariner first reported a position in INmune Bio in Q4 2024 and has held it in 5 quarters since.
  • Mariner's INmune Bio position peaked at $64.6K in Q4 2024.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.